Nitric oxide synthase in diabetic rat testicular tissue and the effects of pentoxifylline therapy

Mehmet Fatih Sönmez1, Eser Kılıç2, Derya Karabulut1

  • 1a Department of Histology and Embryology , Faculty of Medicine, Erciyes University .

Insights

Diabetes negatively impacts male reproductive health, increasing nitric oxide synthase (NOS) in testes. Pentoxifylline treatment shows promise in reversing this diabetes-induced testicular damage.

Area of Science:

  • Reproductive Endocrinology
  • Molecular Biology
  • Diabetology

Background:

  • Diabetes mellitus is linked to male reproductive dysfunction, including hormonal imbalances and reduced semen quality.
  • Nitric oxide synthases (NOS) play a role in testicular function, but their specific involvement in diabetes-associated pathology is not fully understood.

Purpose of the Study:

  • To investigate the molecular effects of NOS on testicular pathology in diabetic rats.
  • To evaluate the therapeutic potential of pentoxifylline in mitigating diabetes-induced testicular damage.

Main Methods:

  • Utilized a rat model of diabetes, divided into control, diabetic, diabetic + pentoxifylline, and pentoxifylline-only groups.
  • Assessed NOS expression (nNOS, iNOS, eNOS) at mRNA and protein levels using qRT-PCR, Western blot, and immunohistochemistry.
  • Evaluated testicular histopathology, seminiferous tubule diameter, Johnsen's score, and serum testosterone levels.

Main Results:

  • Diabetes led to decreased seminiferous tubule diameter, Johnsen's score, and testosterone levels.
  • Diabetic rats exhibited increased apoptotic cells and elevated levels of nNOS, iNOS, and eNOS mRNA and protein.
  • Pentoxifylline treatment reduced NOS levels, suggesting a reversal of diabetes-induced damage.

Conclusions:

  • Diabetes induces testicular damage mediated by increased nitric oxide synthase expression.
  • Pentoxifylline demonstrates potential therapeutic efficacy in reversing diabetes-associated testicular pathology.